XenoGesis


Xenogesis Logo

XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation. The core XenoGesis team has an enviable track record of delivery in drug discovery.

It is clear that identifying poor compounds early through scientific rigor is key in preventing progression into more expensive pre-clinical tests. Even a minor improvement in early-stage drug failure prediction will result in significant time and cost savings for R&D companies. Specifically,XenoGesis can identify the potential 'winners' and 'losers' in a selection of compounds synthesised in drug discovery campaigns. Moreover, providing iterative feedback to the research team based on the results and recommending next steps is a key focus for XenoGesis.

XenoGesis Company Video 2017 from XenoGesis Limited on Vimeo.

Contact XenoGesis via their website


News Archive

09/11/2017   XenoGesis and Juniper Pharma Services strengthen alliance with investment in GastroPlus...more

17/10/2017   XenoGesis and Juniper Pharma Services strengthen alliance with investment in GastroPlus...more
28/09/2017   Meet XenoGesis at several forthcoming events...more
17/08/2017   XenoGesis shortlisted as Finalist at 2017 OBN Awards...more
13/08/2017   XenoGesis and Juniper Pharma Services to deliver joint case study at BOS 2017...more
27/06/2017   Meet XenoGesis and Juniper Pharma Services at BOS Basel 2017...more
14/06/2017   XenoGesis Reports Third Year of Export Growth...more
05/06/2017   Sareum notes Sierra Oncology announcement of Chk1 inhibitor SRA737 encouraging...more
28/04/2017   XenoGesis to join panel at ON Helix Welcome Reception...more
31/03/2017   Latest news from Xenogesis...more
26/03/2017   XenoGesis through to Medilink UK Business Awards in Outstanding Achievement category...more
24/03/2017   Business Development Executive required at Xenogesis - Ends 28/04/2017...more

15/12/2016   XenoGesis opens state-of-the-art Bioanalysis Suite...more
08/11/2016   XenoGesis Celebrates 5th Anniversary...more
21/10/2016   XenoGesis Newsletter: Website, US Expansion, Erasmaus, 5th Birthday...more
29/09/2016   XenoGesis Invests in Agilent AriaMx Real-Time PCR System...more
28/09/2016   Xenogesis Adds CYP Induction And Gene Expression Assays To Its Portfolio...more
16/09/2016   XenoGesis Teams Up With Juniper Pharma Services For BOS London 2016...more
09/09/2016   XenoGesis Has Appointed Sabrina Mogle to Spearhead US Business Development Strategy...more
26/08/2016   XenoGesis joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code